Progyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of "Hold" by Brokerages

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) has been assigned an average rating of "Hold" from the thirteen brokerages that are covering the firm, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $23.64.

Several equities analysts recently issued reports on the company. BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price target on the stock in a research note on Monday, March 31st. Canaccord Genuity Group raised their target price on Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research report on Friday, February 28th. JPMorgan Chase & Co. raised their price objective on shares of Progyny from $17.00 to $23.00 and gave the stock a "neutral" rating in a report on Tuesday, January 28th. Finally, Bank of America lifted their price objective on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a report on Tuesday, February 11th.

Institutional Investors Weigh In On Progyny

Hedge funds have recently modified their holdings of the business. Voya Investment Management LLC lifted its stake in Progyny by 1.4% in the fourth quarter. Voya Investment Management LLC now owns 51,792 shares of the company's stock valued at $893,000 after buying an additional 701 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Progyny by 341.4% during the fourth quarter. GAMMA Investing LLC now owns 1,611 shares of the company's stock worth $28,000 after buying an additional 1,246 shares during the period. Signaturefd LLC raised its position in Progyny by 1,355.0% in the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company's stock valued at $25,000 after buying an additional 1,355 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock worth $51,000 after acquiring an additional 1,526 shares in the last quarter. Finally, KBC Group NV boosted its holdings in Progyny by 84.6% during the fourth quarter. KBC Group NV now owns 4,669 shares of the company's stock worth $81,000 after purchasing an additional 2,140 shares during the last quarter. Institutional investors and hedge funds own 94.93% of the company's stock.

Remove Ads

Progyny Stock Performance

Shares of PGNY traded down $0.27 during mid-day trading on Monday, hitting $21.81. The company's stock had a trading volume of 1,077,203 shares, compared to its average volume of 1,733,621. Progyny has a one year low of $13.39 and a one year high of $33.85. The stock's 50-day moving average is $21.99 and its two-hundred day moving average is $18.76. The firm has a market capitalization of $1.86 billion, a PE ratio of 37.60, a price-to-earnings-growth ratio of 2.39 and a beta of 1.33.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.